• Home
  • About Expert Witness
  • News & Media Coverage
  • Research & Publications
  • Contacts and CV
  • Public speaking
  • Healthcare consulting
  • More
    • Home
    • About Expert Witness
    • News & Media Coverage
    • Research & Publications
    • Contacts and CV
    • Public speaking
    • Healthcare consulting
  • Home
  • About Expert Witness
  • News & Media Coverage
  • Research & Publications
  • Contacts and CV
  • Public speaking
  • Healthcare consulting

Research & Publications

Dr. Mihail Zilbermint published over 60 peer-reviewed journal articles and book chapters.

Download Dr. Zilbermint's CV

Recent Peer-Reviewed Publications

Endocrinology Expert Witness: Bridging Healthcare and Law to Uphold Standards

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

Endocrinology Expert Witness: Bridging Healthcare and Law to Uphold Standards

Endocrinology Expert Witness

Journal of Community Hospital Internal Medicine Perspectives

May 2025

Dr. Mihail Zilbermint and attorney Stacey B. Lee discuss the pivotal role of medical professionals in legal settings, emphasizing the importance of expert witness work in upholding healthcare standards and ensuring justice.

Pituitary Apoplexy Following Gonadotropin-Releasing Hormone Agonist Therapy

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

Endocrinology Expert Witness: Bridging Healthcare and Law to Uphold Standards

Cureus

May 2025

Dr. Mihail Zilbermint and his mentee, Dr. Naghiyeva, describe a very rare case of a life-threatening endocrine emergency following administration of leuprolide for the treatment of prostate cancer.

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

Endocrine Practice

February 2025

Dr. Mihail Zilbermint co-authored this comprehensive guideline, offering evidence-based recommendations for managing dyslipidemia in adults. The guideline emphasizes individualized treatment strategies, including the use of nonstatin therapies, to reduce the risk of atherosclerotic cardiovascular disease.

Expert Clinical Interpretation of CGM Reports From Individuals Without Diabetes

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

AACE Clinical Practice Guideline on Pharmacologic Management of of Adults With Dyslipidemia

Journal of Diabetes Science and Technology

February 2025

Dr. Mihail Zilbermint co-authored this pivotal study, which examines the variability among expert clinicians in interpreting continuous glucose monitoring (CGM) data from individuals without diabetes. The research highlights the lack of consensus in clinical recommendations, underscoring the need for standardized guidelines in this emerging area of metabolic health. 

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

Journal of Community Hospital Internal Medicine Perspectives

January 2025

Dr. Mihail Zilbermint co-authored this case series examining three patients who developed significant hypercalcemia after receiving vancomycin-loaded calcium sulfate beads during orthopedic procedures. The study highlights the importance of monitoring serum calcium and creatinine levels postoperatively in patients treated with these antibiotic beads.

Hyperglycemia Requiring High-Dose Insulin After Supratherapeutic Amlodipine Ingestion

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

Severe Hypercalcemia Following Hip Joint Implantation of Calcium Sulfate Antibiotic Beads

AACE Clinical Case Reports

November–December 2024


Co-authored by Dr. Mihail Zilbermint and his mentee, budding endocrinologist Dr. Kumar, this compelling case report details the management of a 74-year-old man who developed severe nonketotic hyperglycemia after ingesting 88 tablets of amlodipine. The patient required high-dose insulin euglycemic therapy, peaking at 850 U/h, to stabilize his condition.

Inpatient Diabetes Management

Inpatient Diabetes Management

Inpatient Diabetes Management

Annals of the New York Academy of Sciences

July 2024

Hospitalized patients with diabetes face unique and evolving challenges. In this review, Dr. Mihail Zilbermint and colleagues outline the complexities of inpatient diabetes care—from glycemic targets and insulin dosing to discharge planning and hospital-based diabetes technology.

Bibliographic Listings for Dr. Zilbermint

Google Scholar

Copyright © 2025 Endocrinology Expert Advisors, L.L.C. - All Rights Reserved.

Powered by

  • Home

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept